Table 4.

Estimated US prevalence^a of pediatric population with chronic metoclopramide use, by insurance type and age group

	Chronic use (≥35 days): age group					Chronic use (≥130 days): age group
	<1 year	1 year	2–6 years	7–17 years	Total: age 0–17	<1 year	1 year	2–6 years	7–17 years	Total: age 0–17
Medicaid
2008 population	2,415,672	2,064,288	9,523,468	15,188,287		2,415,672	2,064,288	9,523,468	15,188,287
Chronic use (% of population)	0.75	0.41	0.17	0.13		0.15	0.11	0.07	0.05
Prevalence chronic use	18,170	8369	16,371	20,227	63,137	3578	2207	6737	7972	20,494
Privately insured
2008 population	1,717,063	2,036,468	10,526,582	30,632,774		1,717,063	2,036,468	10,526,582	30,632,774
Chronic use (% of population)	0.47	0.27	0.04	0.03		0.12	0.08	0.02	0.01
Prevalence chronic use	8025	5474	3789	8595	25,883	2015	1643	1650	2420	7728
Total with chronic use	26,195	13,843	20,160	28,822	89,020	5593	3850	8387	10,392	28,222

^aDue to rounding, the population counts multiplied by percentages do not exactly match the estimates